About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch

Biovault Technical

About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch
25 June 2026
Cellular Therapies, Quality & Safety
Sarah Conway
What happens after a stem cell donor says yes

Explore the zero-margin-for-error custody chain in PBSC processing. Learn how Biovault Technical meets HTA and JACIE standards to ensure transplant viability.

What happens after a stem cell donor says yes
19 May 2026
Cellular Therapies, Innovation
Sarah Conway
Beyond Oncology: The landmark cellular therapy ...

To mark Clinical Trials Day, we explore 5 landmark international trials redefining cellular therapy. From record-breaking oncology survival data to functional cures for severe autoimmunity and HIV, discover the breakthroughs transforming medicine from the lab to the bedside.

Beyond Oncology: The landmark cellular therapy trials redefining modern medicine
6 May 2026
Quality & Safety, Regulatory Partnerships, Cellular Therapies, Innovation, Ethical Practices
Sarah Conway
Donor lymphocyte infusions: from reactive ...

Donor lymphocyte infusions (DLI) and clinical readiness. Discover Biovault’s pre-prepared DLI processing and storage approach for faster access and reduced risk.

Donor lymphocyte infusions: from reactive intervention to clinical readiness
30 March 2026
Industry Events, Company News, Cellular Therapies
Sarah Conway
EBMT 2026: 5 Insights Shaping the Future of ...

5 key takeaways from EBMT 2026, from expanded cord blood and JACIE quality to regulation, infrastructure and the future of cell therapy.

EBMT 2026: 5 Insights Shaping the Future of Cell Therapy
10 February 2026
Cellular Therapies, Innovation
Sarah Conway
The Evolution of Cell Therapy Part 3: Immune ...

Explore how PBSCs enabled CAR-T and immune effector cell therapies, and how Biovault supports safe processing, storage and delivery of advanced cellular medicines.

The Evolution of Cell Therapy Part 3: Immune Effector Cell Therapies
Sarah Conway
27 October 2025
Quality & Safety, Regulatory Partnerships, Cellular Therapies

The Evolution of Cell Therapy Part 1: Bone Marrow Transplantation

Sarah Conway
27 October 2025
Quality & Safety, Regulatory Partnerships, Cellular Therapies
The Evolution of Cell Therapy Part 1: Bone Marrow Transplantation

From Hiroshima to healing. How bone marrow transplantation progressed from early trials to safe, accredited therapy, with UK pioneers, EBMT standards, and Biovault’s accredited processing.

Sarah Conway
29 September 2025
Innovation

Engineering Cellular Therapy Tools: How Biovault Built Better Cryo Racks

Sarah Conway
29 September 2025
Innovation
Engineering Cellular Therapy Tools: How Biovault Built Better Cryo Racks

How Biovault Technical engineered new cryoshipper racks and CRF freezer racks to enhance safety, usability and compliance for cellular therapies.

Sarah Conway
5 August 2025
Sustainability, Innovation, Ethical Practices

Biovault Halves Emissions in Under Five Years on Road to Net Zero

Sarah Conway
5 August 2025
Sustainability, Innovation, Ethical Practices
Biovault Halves Emissions in Under Five Years on Road to Net Zero

As the UK’s ethical bioresource, Biovault is leading the way in slashing processing and storage emissions as part of its pledge to achieve Net Zero.

Sarah Conway
8 July 2025
Quality & Safety

Cryogenic Confusion: How terminology and tolerance can jeopardise biological samples

Sarah Conway
8 July 2025
Quality & Safety
Cryogenic Confusion: How terminology and tolerance can jeopardise biological samples

Clarify cold storage confusion. Learn how to define, map, and monitor temperature ranges accurately across cryogenic and controlled environments.

Sarah Conway
18 June 2025
Quality & Safety, Regulatory Partnerships

Beyond Storage: Why Uninterrupted Continuity is Non-Negotiable for Biological Assets

Sarah Conway
18 June 2025
Quality & Safety, Regulatory Partnerships
Beyond Storage: Why Uninterrupted Continuity is Non-Negotiable for Biological Assets

We explore why robust contingency planning is not just a best practice, but an essential component of responsible biomedical research and advanced cellular therapies.

Sarah Conway
13 May 2025
Industry Events, Company News, Cellular Therapies

What EBMT 2025 Told Us About the Future of Cell Therapy

Sarah Conway
13 May 2025
Industry Events, Company News, Cellular Therapies
What EBMT 2025 Told Us About the Future of Cell Therapy

Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.

Newer Posts
Older Posts
Back to Top
Biovault Technical Ltd, Plymouth International Medical & Technology Park, 24 Brest Road, Derriford, Plymouth, PL6 5XP, United Kingdom+44 1752 753720info@biovaulttechnical.co.uk

address

Biovault Technical
24 Brest Road
Plymouth, PL6 5XP
View on map

TELEPHONE

+44 (0)1752 753720

enquiries

info@biovaulttechnical.co.uk

careers

COOKIE POLICY

Privacy Policy

CONTACT